Pigs are omnivores which live on a diet of meat and plants. These animals are farmed for food (bacon, pork, etc.) and skin. Porcine vaccines are drugs administered to swine to protect them against the gamut of diseases. Some of the vaccines are coated without gelatin in order to prevent the possibility of allergic reactions. The global porcine vaccines market report by Market Research Future (MRFR) encompasses a list of trends and opportunities backed by qualitative and quantitative analysis.

Market Outlook

The global porcine vaccines market share is expected to touch a towering valuation by exhibiting 7.30% CAGR from 2020 to 2030 (forecast period). It stood at a value of USD 1,910 million in 2017. Rise in the cases of porcine epidemic diarrhea and other swine diseases is the primary driver of the market. Availability of swine vaccines for ensuring the health of pigs and hogs can bode well for the market. For instance, Zoetis was granted an approval by the U.S. Department of Agriculture (USDA) in 2014 for their vaccine for fighting porcine epidemic diarrhea virus (PEDv). Investment by biotechnology companies for developing formulation to counter new viruses can positively impact the market growth.

Government initiatives for encouraging animal husbandry combined with immense demand for pork and bacon is touted to drive the demand for vaccines. Large number of hog farms due to export of pig end products to Asia and other continents can bolster the market size. The high per capita meat consumption by countries in the European Union (EU) can facilitate the growth of the global porcine vaccines market. But high storage cost of these vaccines may hamper the market growth.

Segmentation Analysis

The global porcine vaccines market share is segmented by type, disease indication, and end-user.

By type, it is segmented into toxoid vaccines, recombinant vaccines, conjugate vaccines, inactivated vaccines, DNA vaccines, and live attenuated vaccines.

By disease indication, it is segmented into porcine circovirus associated disease (PCVAD), porcine epidemic diarrhea (PED), swine influenza, porcine reproductive respiratory syndrome (PRRS), Aujeszky's disease (AD), and others.

By end-user, it is segmented into hog production farm and veterinary hospitals.

Request Free Sample Copy at:

https://www.marketresearchfuture.com/sample_request/7438

Regional Analysis

Europe, the Middle East Africa (MEA), Asia Pacific (APAC), and the Americas are regions covered in the porcine vaccines market share report.

The Americas are estimated to be the dominating region due to subsequent rise of pig farming and increasing cases of swine diseases. Increase in pig cultivation and contract farming in the U.S. is deemed to trigger the market demand by 2023. Expansion of production facilities in the U.S. due to rising export of pig products for consumption can positively impact the regional market growth. On the other hand, the Europe region can exhibit a remarkable CAGR during the forecast period due to high consumption rate of pork and other types of swine meat.

The APAC region is touted to grow at a robust velocity due to various initiatives by government agencies, development of new vaccines, and presence of numerous animal health companies. Outbreaks of African swine fever (ASF) and fears of pigs contracting the disease can propel the demand for porcine vaccines in the region. Recommendation by veterinarians for the prevention of the spread of the contagion among pig herds can fuel market demand. Lastly, the MEA region accounted for the lowest market share due to the slow boom experienced by the domestic animal husbandry sector and resistance from countries in the Middle East.

Competitive Outlook

Bayer AG, PBS Animal Health, Ceva Sante Animale, Vetoquinol S.A., Merck Co., Inc., Bimeda, Inc., Zoetis, Inc., Eli Lilly and Company, Sanofi S.A., Boehringer Ingelheim International GmbH, and Aptimmune are some of the reputed players in the global porcine vaccines market. Development of new products to expand offerings, acquisitions, and expansions are prime strategies of players in the market. Recently, Elanco Animal Health acquired Prevtec Microbia, a startup specializing in development of vaccines for animal health.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/porcine-vaccines-market-7438

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com